Sara Dhanani

American Board of Neurology and Psychiatry - current

Board Certified in Neurology and Psychiatry - current

American Academy of Neurology

Movement Disorder Society

Parkinson's Study Group

Huntington's Study Group

Arizona Medical Board

Banner Secondary Professional Activities Committee (SPAC) -03/2023 - current

2024: Role of Neuromodulation and Advanced therapies in PD

2019 - Advanced therapeutics in Parkinson's Disease

2018- Role of DBS in managing Parkinson's Disease

2018: Treatment for Tremors

2017: Cognition & Psychosis in PD

2017 -Cognitive Impairment in Parkinson's Disease

2016: Treating Women with Parkinson's Disease

2022 - Arts on the Brain, Neurosymposium, University of Arizona, College of Medicine, Phoenix, AZ

2020 - Avoiding Dementia as a complication of DBS, Annual Symposium on Alzheimer's,Lewy body and related Dementia's, Sun City, AZ

2012 - Deep Brain Stimulation (DBS) targeting for Parkinson's Disease; Sub Thalamic nucleus (STN) versus Internal Globus Pallidus (GPi) surgery, BNI Neuroscience Grand Rounds, St Josephs Medical Center, Phoenix, AZ

2011 - Neurologic manifestations of Thiamine deficiency”, INI Neuroscience Grand Rounds - OSF St Francis Medical Center, Peoria, IL

2010 - Frontotemporal Dementia”, INI Neuroscience Grand Rounds - OSF St Francis Medical Center, Peoria, IL

2009- Post Stroke Depression”, INI Neuroscience Grand Rounds - OSF St Francis Medical Center, Peoria, IL

2018 - Current: Movement Disorders Rotation, Banner University Medical Center, Phoenix. Organized rotation curriculum/logistics including resident lectures divided among three or more faculty for neurology residents

2023 - Current: Movement Disorder Lecture, University of Arizona Medical School, Organized lecture series for medical students (M1-M2)

2020 - Current: Neurology elective training with M3 and M4 students

2023 - Current: Medical student mentorship withUniversity of Arizona Medical students showing interest in Neurology

09/01/20 - Present Study Comparing Continuous Subcutaneous Infusion Of ABBV-951 With Oral Carbidopa/Levodopa Tablets For Treatment Of Motor Fluctuations In Adult Participants With Advanced Parkinson's Disease AbbVie Inc.

Role: Site Principal-Investigator

06/01/20 - Present Extension Study To Evaluate Safety And Tolerability Of 24-Hour Daily Exposure Of Continuous Subcutaneous Infusion of ABBV-951 In Adult Participants With Parkinson's Disease AbbVie Inc.

Role: Site Principal-Investigator

07/11/22 - Present A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared with Placebo in Participants With Early PD Annovis

Role: Site Sub Investigator

09/05/22 - Present Study to Assess the Safety of BIIB122 Tablets and if it Can Slow the Worsening of Early Stage Parkinson's Disease in Participants Between the Ages of 30 and 80 LUMA Biogen/Denali Therapeutics Inc

Role: Site Sub Investigator

08/03/22 - Present Study to Evaluate the Safety and Efficacy of JZP385 in the Treatment of Adults with Moderate to Severe Essential tremor Jazz Pharmaceuticals

Role: Site Sub Investigator

07/11/22 - Present Study to Evaluate the Safety, Tolerability and Efficacy of CT1812 in Subjects With Mild to Moderate Dementia With Lewy Bodies (COG1201) Cognition Therapeutics

Role: Site Sub Investigator

05/03/21 - Present A Clinical Study of NLY01 in Patient's With Early Parkinson's Disease Neuraly

Role: Site Sub Investigator

04/05/21 - Present A Validation Study to Assess the Validity, Measurement Responsiveness, & Reliability of the Parkinson's Disease Functional Impacts Digital Instrument (PD-FIDI) in Patients with Parkinson's Disease (PD) with or without Glucocerebrosidase (GBA) Mutations Sanofi-Aventis

Role: Site Sub Investigator

11/1/2023 -12/15/2023 - A Study of SAGE-324 for the treatment of Essential Tremor (SAGE therapeutics)

Role: Site Principal Investigator

08/31/2022 - 07/31/2023 - a Study to evaluate the effects of SAGE 718 in Parkinson's Disease Cognitive Impairment

Role: Site Principal Investigator

02/01/22 – 12/20/22 A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's Disease (PADOVA) Role: Site Sub Investigator

04/26/21 - 07/11/22 A Study of E2027 in Participants With Dementia With Lewy Bodies or Parkinson's Disease Dementia With or Without Amyloid Co-pathology Eisai, Inc.

Role: Site Sub Investigator

06/03/19 - 12/31/20 Study To Evaluate the Efficacy, Safety and Tolerability of E2027 in Participants With Dementia With Lewy Bodies Eisai, Inc. Role: Site sub Investigator

04/01/19 - 09/01/21 Clinical Effect of Ampreloxetine (TD-9855) for Treating symptomatic neurogenic Orthostatic Hypotension in Subjects With Primary Autonomic Failure Theravance

Role: Site Sub Investigator

03/01/19 - 11/30/19 Orally Administered ENT-01 for Parkinson's Disease-Related Constipation (KARMET) Enterin Inc.

Role: Site Sub Investigator

12/01/18 - 06/01/21 The INSYTE (Management of Parkinson's Disease Psychosis in Actual Practice) Study ACADIA Pharmaceuticals Inc. Role: Sub Investigator

Fung, Victor; Aldred, Jason; Arroyo, Martha; Bergquist, Filip; Boon, Agnita; Bouchard, Manon; Bray, Sarah; Dhanani, Sara ; Facheris, Maurizio; Fisseha, Nahome; Freire Alvarez, Eric; Hauser, Robert; Jeong, Anna; Jia, Jia; Kukreja, Pavnit; Soileau, Michael; Spiegel, Amy; Talapala, Saritha; Tarakad, Arjun; Urrea-Mendoza, Enrique; Zamudio, Jorge; Pahwa, Rajesh. Subcutaneous Foslevodopa/Foscarbidopa Infusion for the Treatment of Motor Fluctuations in Parkinson's Disease: Considerations for Initiation and Maintenance: Clinical Parkinsonism & Related Disorders - Clin Park Relat Disod.

Pooja, Dhupati;Priya Ramiah;Robert Bina; Sara Dhanani. Role of Pre-operative Mild Cognitive Impairment in Patients Undergoing Deep Brain Stimulation for Parkinson's Disease: Systematic Review. AAN 2024

Kern, Drew; Isaacson, Stuart; Dhanani, Sara ; Aldred, Jason; Bergmans, Bruno; Santos Garcia, Diego; Oeda, Tomoko; Gandor, Florin; Kukreja, Pavnit; Bergmann, Lars; Gupta, Resmi; Talapala, Saritha; Spiegel, Amy; Kimber, Thomas. Safety of foslevodopa/foscarbidopa during optimization and maintenance treatment: Post hoc analysis of a phase 3, single-arm trial. Movement Disorders Society Annual Meeting 2023. https://www.mdsabstracts.org/abstract/safety-of-foslevodopa-foscarbidopa-during-optimization-and-maintenance-treatment-post-hoc-analysis-of-a-phase-3-single-arm-trial/

Henriksen, Tove; Martinez Castrillo, Juan Carlos; Huisman, Mark H.B.; Dhanani, Sara; Peckham, Elizabeth; Aldred, Jason; Bergmann, Lars; Shah, Megha; Gupta, Resmi; Kukreja, Pavnit; Fung, Victor. Efficacy and safety of foslevodopa/foscarbidopa subcutaneous infusion in patients with prior deep brain stimulation. Parkinsonism and Related Disorders,Vol 122,May 2024. 10.1016/j.parkreldis.2024.106150

Odin, Per; Kimber, Thomas; Bergmans, Bruno; Freire Alvarez, Eric; Gandor, Florin; Isaacson, Stuart; Dhanani, Sara; Hauser, Robert; O'Meara, Marie; Jeong, Anna; Jia, Jia; Gupta, Resmi; Bergmann, Lars; Shah, Megha; Harmer, Linda; Talapala, Saritha; Aldred, Jason. Integrated analysis of phase 3 trials of foslevodopa/foscarbidopa demonstrated that majority of reported infusion site AEs including infections were non serious, mild to moderate in severity and did not result in treatment discontinuation. Movement Disorders Society Annual Meeting 2023. https://www.mdsabstracts.org/abstract/integrated-analysis-of-phase-3-trials-of-foslevodopa-foscarbidopa-demonstrated-that-majority-of-reported-infusion-site-aes-including-infections-were-non-serious-mild-to-moderate-in-severity-and-did-n/.

Fung, Victor; Bergquist, Filip; Dhanani, Sara ; Facheris, Maurizio; Gandor, Florin; Isaacson, Stuart; Jeong, Anna; Jia, Jia; Spiegel, Amy; Aldred, Jason

Long-Term Safety and Tolerability of Foslevodopa/Foscarbidopa for Treatment of Motor Fluctuations in Parkinson's Disease; Annual Academy of Neurology 2024

Odin, Per; Kimber, Thomas; Bergmans, Bruno; Freire Alvarez, Eric; Gandor, Florin; Isaacson, Stuart; Dhanani, Sara; Hauser, Robert; O'Meara, Marie; Jeong, Anna; Jia, Jia; Gupta, Resmi; Bergmann, Lars; Shah, Megha; Harmer, Linda; Talapala, Saritha; Aldred, Jason. Integrated analysis of phase 3 trials of foslevodopa/foscarbidopa demonstrated that majority of reported infusion site AEs including infections were non serious, mild to moderate in severity and did not result in treatment discontinuation: Abstract DPG 2024

Kern, Drew; Isaacson, Stuart; Dhanani, Sara ; Aldred, Jason; Bergmans, Bruno; Santos Garcia, Diego; Oeda, Tomoko; Gandor, Florin; Kukreja, Pavnit; Bergmann, Lars; Gupta, Resmi; Talapala, Saritha; Spiegel, Amy; Kimber, Thomas. Safety of foslevodopa/foscarbidopa during optimization and maintenance treatment: Post hoc analysis of a phase 3, single-arm trial. Abstract DPG 2024

Henriksen, Tove; Martinez Castrillo, Juan Carlos; Huisman, Mark H.B.; Dhanani, Sara ; Peckham, Elizabeth; Aldred, Jason; Bergmann, Lars; Shah, Megha; Gupta, Resmi; Kukreja, Pavnit; Fung, Victor. Efficacy and safety of foslevodopa/foscarbidopa subcutaneous infusion in patients with prior deep brain stimulation. World Congress of Parkinsons Disease and Related Disorders 2024

Fung, Victor; Bergquist, Filip; Dhanani, Sara ; Facheris, Maurizio; Gandor, Florin; Isaacson, Stuart; Jeong, Anna; Jia, Jia; Spiegel, Amy; Aldred, Jason

Long-Term Safety and Tolerability of Foslevodopa/Foscarbidopa for Treatment of Motor Fluctuations in Parkinson's Disease. DGN 2024

Odin, Per; Kimber, Thomas; Bergmans, Bruno; Freire Alvarez, Eric; Gandor, Florin; Isaacson, Stuart; Dhanani, Sara ; Hauser, Robert; O'Meara, Marie; Jeong, Anna; Jia, Jia; Gupta, Resmi; Bergmann, Lars; Shah, Megha; Harmer, Linda; Talapala, Saritha; Aldred, Jason. Integrated analysis of phase 3 trials of foslevodopa/foscarbidopa demonstrated that majority of reported infusion site AEs including infections were non serious, mild to moderate in severity and did not result in treatment discontinuation. ATMRD 2024

S Dhanani , A Lieberman, R Dhall, and D Pan, “Identifying Risk Factors for Falls in Parkinson's Disease using Non-UPDRS Balance Tests”, 65th Annual Meeting of the American Academy of Neurology, March 16–23, 2013, San Diego

R Dhall, N Krishnamurthi, A Lieberman, S Dhanani , and D Pan, MS, “Why Levodopa may Increase Falls in Parkinson's disease” ,” 65th Annual Meeting of the American Academy of Neurology, March 16–23, 2013, San Diego

A Lieberman, N Krishnamurthi, R Dhall, A Santiago, S Dhanani , and D Pan, “A Simple Means of Distinguishing the Tremor of Parkinson Disease from Essential Tremor: the Alien Finger”, 65th Annual Meeting of the American Academy of Neurology, March 16–23, 2013, San Diego

A Lieberman, N Krishnamurthi, R Dhall, S Dhanani , and D Pan, “Identifying Risk Factors for Falls in Parkinson's Disease using the UPDRS”, 65th Annual Meeting of the American Academy of Neurology, March 16–23, 2013, San Diego

A. Lieberman, N. Krishnamurthi, A. Santiago, R. Dhall, G. Moguel-Cobos, A. Sadreddin, S. Husain, N. Salins, D. Pan, and S. Dhanani , “Is difficulty with balance different than difficulty walking in Parkinson's disease”, 64th Annual Meeting of the American Academy of Neurology, April 21-28, New Orleans, LA

S Dhanani , N. Krishnamurthi, A. Santiago, R. Dhall, G. Moguel-Cobos, A. Sadreddin, S. Husain, N. Salins, A. Lieberman and D. Pan, “Effects of bradykinesia and hypokinesia on falls in Parkinson's disease”, 64th Annual Meeting of the American Academy of Neurology, April 21-28, New Orleans, LA

S. Husain, N. Krishnamurthi, A. Santiago, R. Dhall, G. Moguel-Cobos, A. Sadreddin, N. Salins, D. Pan, A. Lieberman, and S. Dhanani ,“The value of the Barrow Neurological Institute balance scale in prediction falls”, 64th Annual Meeting of the American Academy of Neurology, April 21-28, New Orleans, LA

N. Salins, N. Krishnamurthi, A. Santiago, R. Dhall, G. Moguel-Cobos, A. Sadreddin, S. Husain, A. Lieberman, D. Pan, and S. Dhanani , “Gait and posture control impairments predict falls in Parkinson's disease”, 64th Annual Meeting of the American Academy of Neurology, April 21-28, New Orleans, LA

S Dhanani , J Pula and J Kattah,“Bilateral vestibulopathy in thiamine-folate deficiency with rapid clinical response to IV thiamine replacement”, 63rd Annual Meeting of the American Academy of Neurology, April 9 -April 16, 2011. Honolulu, Hawaii

R Valenzuela, S Dhanani , G Blume, D Garwacki, “Correlation between Relapses in Multiple Sclerosis and Ambient Air Quality in Central Illinois”, Resident Research Day, OSF St Francis Medical Center, May 2011

Principles and Practiceof Stereotactic Radiosurgery, Second Edition; Movement Disorders: Viewpoint—Medical Therapy: Abraham N. Lieberman and Sara S. Dhanani

A Lieberman, S Dhanani , R Dhall, Di Pan, “A quick and easy-to-use clinical scale to assess balance in Parkinson's disease”, Journal of Parkinsonism & Restless Legs Syndrome 2012:2 67–71

This is a true and accurate statement of my activities and accomplishments. I understand that misrepresentation in securing promotion and tenure may lead to dismissal or suspension under ABOR Policy 6-201 J.